Let us see if there are any changes when there is the Masters's deal, new patents, etc.MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 19 May 2023: Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer of Alterity will present at the SHARE Series Monday Management Update on Monday, May 22, 2023, at 11:00 am ET or 1:00am AEST Tuesday, May 23 2023.
This event is set in a fireside chat format and intended for retail and institutional investors. Investors will have the opportunity to ask questions during the chat.A link to the live and archived webcast may be accessed on the Alterity website under the Investors section Events and Presentations, or directly at https://www.openexchange.tv/share-series. An archived replay will be available for approximately 90 days following the event.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $119.6M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.1¢ | 1.0¢ | $46.86K | 4.283M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 64 | 25268416 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 18128695 | 9 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| ATH (ASX) Chart |